Clinical Trial Results: Thromboembolic Risk Screening in Patients With Cancer and COVID-19 [NA]

View source ↗

Summary

A completed clinical trial evaluating thromboembolic risk screening in patients with cancer and COVID-19; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Neoplasms Malignant, Covid19 | NA | Status: COMPLETED | Results posted: 2026-07-01